Organization Profile

You just read:

Hospira's Inflectra™ (infliximab) the first biosimilar monoclonal antibody to receive positive opinion from EMA's CHMP for rheumatoid arthritis, inflammatory bowel disease and plaque psoriasis

News provided by

Hospira, Inc.

Jun 28, 2013, 07:41 ET